CYXTERA TECHNOLOGIES INC (CYXT)
US23284C1027 - Common Stock
CYXT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 86 industry peers in the IT Services industry. Both the profitability and financial health of CYXT have multiple concerns. CYXT is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CYXT had negative earnings in the past year.
CYXT had a positive operating cash flow in the past year.
CYXT had negative earnings in each of the past 5 years.
CYXT had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The profitability ratios for CYXT are negative, so there is not much use analyzing them.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CYXT has a better Gross Margin (46.37%) than 71.43% of its industry peers.
In the last couple of years the Gross Margin of CYXT has grown nicely.
CYXT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 46.37% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.68%
GM growth 5YN/A
2. Health
2.1 Basic Checks
CYXT does not have a ROIC to compare to the WACC, probably because it is not profitable.
CYXT has more shares outstanding than it did 1 year ago.
CYXT has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -0.82, we must say that CYXT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CYXT (-0.82) is worse than 81.32% of its industry peers.
A Debt/Equity ratio of 31.18 is on the high side and indicates that CYXT has dependencies on debt financing.
With a Debt to Equity ratio value of 31.18, CYXT is not doing good in the industry: 81.32% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 31.18 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.82 |
ROIC/WACCN/A
WACC1.73%
2.3 Liquidity
A Current Ratio of 0.43 indicates that CYXT may have some problems paying its short term obligations.
CYXT has a Current ratio of 0.43. This is amonst the worse of the industry: CYXT underperforms 90.11% of its industry peers.
CYXT has a Quick Ratio of 0.43. This is a bad value and indicates that CYXT is not financially healthy enough and could expect problems in meeting its short term obligations.
CYXT's Quick ratio of 0.43 is on the low side compared to the rest of the industry. CYXT is outperformed by 89.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.43 | ||
| Quick Ratio | 0.43 |
3. Growth
3.1 Past
CYXT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.83%.
CYXT shows a small growth in Revenue. In the last year, the Revenue has grown by 6.60%.
CYXT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.21% yearly.
EPS 1Y (TTM)-19.83%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-13.04%
Revenue 1Y (TTM)6.6%
Revenue growth 3Y3.21%
Revenue growth 5YN/A
Revenue growth Q2Q7.84%
3.2 Future
Based on estimates for the next years, CYXT will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.65% on average per year.
CYXT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.62% yearly.
EPS Next Y8.38%
EPS Next 2Y9.18%
EPS Next 3Y9.65%
EPS Next 5YN/A
Revenue Next Year5%
Revenue Next 2Y4.78%
Revenue Next 3Y5.1%
Revenue Next 5Y4.62%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
CYXT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CYXT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
73.63% of the companies in the same industry are more expensive than CYXT, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.15 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.18%
EPS Next 3Y9.65%
5. Dividend
5.1 Amount
No dividends for CYXT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CYXTERA TECHNOLOGIES INC
NASDAQ:CYXT (6/14/2023, 8:24:44 PM)
After market: 0.0595 -0.01 (-8.46%)0.065
+0.02 (+55.5%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap11.68M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 46.37% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 31.18 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.43 | ||
| Quick Ratio | 0.43 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-19.83%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y8.38%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)6.6%
Revenue growth 3Y3.21%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y